Study Shows Citrus Compounds in Orange Juice Affect Genes Linked to Vascular Function

Recent research has indicated that drinking orange juice may influence genes involved in cardiovascular and blood vessel function. A clinical trial involving 37 healthy men with a higher waist circumference found that daily intake of 330 ml of 100% orange juice for six weeks resulted in noticeable molecular effects linked to vascular health.

Citrus bioactives, such as hesperidin—found abundantly in oranges—were absorbed by the participants, affecting the activity of genes associated with the function of blood vessels. Despite these changes, there was no short-term improvement in blood pressure or vessel health noted over the course of the study.

The study, published in Food & Function, reveals that while previous research offers mixed results regarding the impact of orange juice on blood pressure, hesperidin and similar compounds are biologically active and suggest potential pathways for long-term vascular benefits.

Lead researcher Dr. Christine Morand, of the Human Nutrition Unit in France, noted the study’s significance in demonstrating the bioactive nature of orange juice compounds, providing a foundation for further research on their health impacts. Registered Dietitian Dr. Frankie Phillips remarked on the importance of understanding how regular consumption of everyday foods like orange juice can benefit heart health.

Each participant alternated between consuming orange juice, a sugar-matched control drink, and the same control drink with added hesperidin, mirroring the levels found in orange juice. The findings suggest that a small, regular serving of orange juice could be valuable for cardiovascular health, as it did not negatively affect weight, blood glucose, insulin, or cholesterol levels.

This trial emphasizes the need for longer-term studies to ascertain whether the gene expression changes translate into tangible vascular health benefits over time.